R

Anchorvale Diagnostics Pte. Ltd.

202318472KLive
0Particulars tracked
0Open differences
0Days to next check
Source keyConfirmed with ACRAYou told usWorked out by usChecked by usRead only · changes go through Regivue

Open differences with ACRA

REC/DIFF
2 OPEN

We show every difference between our copy and ACRA in the open, including the ones we caused. Each one names who has to close it.

DIFF-01

Registered office

Our moveSpotted 11 Aug 2026

We lodged your change of address with ACRA on 8 August 2026. ACRA has not shown the new unit yet. Nothing is needed from you — we are watching for it to land.

ACRA holds60 Paya Lebar Road, #09-14 Paya Lebar Square, Singapore 409051
We hold60 Paya Lebar Road, #10-01 Paya Lebar Square, Singapore 409051
Difference: Unit number
DIFF-02

Residential address of a director · Priya Nathan

Your moveSpotted 15 Aug 2026

ACRA holds a different home address for this director from the one we hold. Please confirm which one is current, and we will prepare the filing.

ACRA holds•••• ••••••••• •••• ••••••• ••••••
We hold•••• ••••••••• •••• ••••••• ••••••
Difference: Whole addressEvery reveal is recorded

Check against ACRA

REC/CLOCK
3
Day 3 / 90
Last checked
15 Aug 2026, 6.12am SGT
Next check
Within 90 days · 87 to go
Compared last time
20 particulars · 2 differed
Activity

Name change recorded — Anchorvale Bio to Anchorvale Diagnostics

02 Nov 2024 · 09:20 — completed

Registered particulars

REC/PART
Source in the left channel
SrcParticularValueAs atRequest a change
Identity
Company nameAnchorvale Diagnostics Pte. Ltd.15 Aug 2026
Former nameAnchorvale Bio Pte. Ltd.Used until 2 Nov 202415 Aug 2026
UEN202318472K15 Aug 2026
Entity typePrivate Company Limited by Shares15 Aug 2026
StatusLive15 Aug 2026
Incorporated14 March 202315 Aug 2026
Premises and hours
Registered office60 Paya Lebar Road, #10-01 Paya Lebar Square, Singapore 409051DIFF-01ACRA still shows the old unit11 Aug 2026
Declared office hoursMonday to Friday, 9.00am – 5.00pmNot something ACRA holds3 Feb 2026
Financial year
Financial Year End31 December15 Aug 2026
Current period1 Jan 2026 – 31 Dec 2026From the year end above15 Aug 2026
Business activity
Primary activity72102 — Research and experimental development on medical and health sciencesSSIC 202015 Aug 2026
Secondary activity46441 — Wholesale of pharmaceutical and medical goodsSSIC 202015 Aug 2026
Goods and Services Tax
GST registration202318472K2 Jul 2026
Registered from1 July 20242 Jul 2026
Filing frequencyQuarterly2 Jul 2026
Custody
Company sealHeld by Regivue in safe custodySince incorporation14 Mar 2023

You cannot edit these directly. A change is a filing we prepare, and a Registered Qualified Individual at Regivue approves it before it goes to ACRA.

Worked out from this record

REC/CALC
Open any one to see its inputs

Audit exemption

Exempt — small company

Two of the three size tests are met across two financial years.

Revenue
S$6,400,000
✓ Met
Total assets
S$4,100,000
✓ Met
Employees
62
✕ Not met
Years assessed
FY2024 and FY2025

Two of three tests, held over two consecutive financial years.

Exempt Private Company

Yes

No company holds shares in you, and you are inside the member limit.

XBRL tier

Simplified

Set by your company type and your audit exemption position.

Dormancy

Not dormant

Accounting transactions have been recorded in this period.

Standing notice

This screen is Regivue’s reconciled copy of the company record. ACRA’s electronic register is the statutory record. If the two ever disagree, ACRA prevails — and we show you the disagreement here rather than smoothing it over.

Reconciled 15 Aug 2026 · 06:12 SGT